95 related articles for article (PubMed ID: 15172637)
1. Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line.
Supriatno ; Harada K; Kawaguchi S; Onoue T; Yoshida H; Sato M
Oral Oncol; 2004 Aug; 40(7):679-87. PubMed ID: 15172637
[TBL] [Abstract][Full Text] [Related]
2. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.
Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M
Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407
[TBL] [Abstract][Full Text] [Related]
3. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line.
Supriatno ; Harada K; Kawaguchi S; Yoshida H; Sato M
Oncol Rep; 2003; 10(3):527-32. PubMed ID: 12684618
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus expressing mutant p27kip1 enhanced apoptosis against cholangiocarcinoma than adenovirus-p27kip1 wild type.
Sasaki T; Katayose Y; Suzuki M; Yamamoto K; Shiraso S; Mizuma M; Unno M; Takeuchi H; Lee CT; Matsuno S
Hepatogastroenterology; 2004; 51(55):68-75. PubMed ID: 15011833
[TBL] [Abstract][Full Text] [Related]
5. High antitumor activity using intratumoral injection of plasmid DNA with mutant-type p27Kip1 gene following in vivo electroporation.
Harada K; Supriatno ; Kawaguchi S; Onoue T; Kawashima Y; Yoshida H; Sato M
Oncol Rep; 2005 Feb; 13(2):201-6. PubMed ID: 15645112
[TBL] [Abstract][Full Text] [Related]
6. Basic investigation on the development of molecular targeting therapy against cyclin-dependent kinase inhibitor p27Kip1 in head and neck cancer cells.
Supriatno ; Harada K; Yoshida H; Sato M
Int J Oncol; 2005 Sep; 27(3):627-35. PubMed ID: 16077910
[TBL] [Abstract][Full Text] [Related]
7. Effect of intratumoral injection of mutant type p27Kip1 followed by in vivo electroporation on radiotherapy-resistant human oral tongue cancer xenografts.
Supriatno ; Yuletnawati SE; Widiasto A
Mol Med Rep; 2011; 4(1):41-6. PubMed ID: 21461561
[TBL] [Abstract][Full Text] [Related]
8. An adenovirus expressing mutant p27 showed more potent antitumor effects than adenovirus-p27 wild type.
Park KH; Seol JY; Kim TY; Yoo CG; Kim YW; Han SK; Shim YS; Lee CT
Cancer Res; 2001 Aug; 61(16):6163-9. PubMed ID: 11507068
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
Shiraso S; Katayose Y; Yamamoto K; Mizuma M; Yabuuchi S; Oda A; Rikiyama T; Onogawa T; Yoshida H; Hayashi H; Ohtsuka H; Motoi F; Egawa S; Kato J; Unno M
Anticancer Res; 2009 Jun; 29(6):2015-24. PubMed ID: 19528460
[TBL] [Abstract][Full Text] [Related]
10. Promotion of cell differentiation, and suppression of cell growth and cyclooxygenase-2 expression by differentiation-inducing agents in human oral squamous carcinoma SCC25 cells.
Kuroda J; Urade M; Kishimoto H; Noguchi K; Hashitani S; Sakurai K; Nishimura N; Hashimoto-Tamaoki T
Int J Oncol; 2005 Feb; 26(2):361-7. PubMed ID: 15645120
[TBL] [Abstract][Full Text] [Related]
11. Low p27Kip1 expression is associated with poor prognosis in oral squamous cell carcinoma.
Harada K; Supriatno ; Yoshida H; Sato M
Anticancer Res; 2002; 22(5):2985-9. PubMed ID: 12530030
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of iNOS gene suppresses the tumorigenicity and metastasis of oral cancer cells.
Harada K; Supriatno ; Kawaguchi S; Tomitaro O; Yoshida H; Sato M
In Vivo; 2004; 18(4):449-55. PubMed ID: 15369183
[TBL] [Abstract][Full Text] [Related]
13. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M
Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
[TBL] [Abstract][Full Text] [Related]
15. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
16. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
17. Establishment of ponasterone A-inducible the wild-type p53 protein-expressing clones from HSC-1 cells, cell growth suppression by p53 expression and the suppression mechanism.
Hori M; Suzuki K; Udono MU; Yamauchi M; Mine M; Watanabe M; Kondo S; Hozumi Y
Arch Dermatol Res; 2009 Oct; 301(9):631-46. PubMed ID: 19009304
[TBL] [Abstract][Full Text] [Related]
18. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma.
Tsai WC; Tsai ST; Jin YT; Wu LW
Mol Cancer Res; 2006 Aug; 4(8):539-47. PubMed ID: 16908593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
